Target intelligence / Profile preview

Nucleophosmin 1 pseudogene 32 (NPM1P32)

Target: NPM1P32
Molecular classification: Other (Pseudogene)

Overview

Nucleophosmin 1 pseudogene 32 (NPM1P32) is a pseudogene, meaning it is a non-functional genomic DNA sequence originally derived from the protein-coding NPM1 gene. Pseudogenes typically do not produce functional proteins and are generally not considered therapeutic drug targets, receptors, enzymes, or biomarkers. There is no evidence in publicly available biomedical literature or genomics databases that NPM1P32 has a direct biological function or role in human disease, or that it is targeted by any drugs. Its name and relationship are based on homology to the functional nucleophosmin 1 gene.

Other names: NPM1P32

Beyond the preview

Go deeper on Nucleophosmin 1 pseudogene 32 (NPM1P32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleophosmin 1 pseudogene 32 (NPM1P32).

Explore the full profile